Turq-101

Inflammatory Bowel Disease

PreclinicalActive

Key Facts

Indication

Inflammatory Bowel Disease

Phase

Preclinical

Status

Active

Company

Exosome‑engineered delivery platform for targeted therapeutics across oncology and autoimmune diseases.

Drug	Company	Phase	Status
DVI-001	Divamics	Preclinical	Approaching PCC selection
DVI-002	Divamics	Preclinical	Lead optimization
GS-4875	Gilead	Phase 2	Active
Function-based Consortium for IBD	PharmaBiome	Pre-clinical	Active
Galapagos Collaboration	Scipher Medicine	Discovery/Pre-clinical	Active
IBD Subclassification	Bio-Me	Research	Active
Anti-iRhom2 antibodies	SciRhom	Pre-clinical	Active
IBD Multi-omics Dataset	Ovation.io	Commercial	Active
Noa‑001	Noa Therapeutics	Preclinical	Active
Inflectra	EMS	Phase 3	Active
IW-601	ImmuneWalk Therapeutics	Preclinical	Active
TRWR‑IBD	Taiwan Resonant Waves Research	Preclinical	Active